Combined modality radioimmunotherapy: synergistic effect of Paclitaxel and additive effect of Bevacizumab

INTRODUCTION: This study was undertaken to investigate the effect of Paclitaxel and Bevacizumab on the therapeutic efficacy of (90)Y-labeled B3 mAb, directed against Le(y) antigen, for the treatment of Le(y)-positive A431 tumors implanted s.c. in the right hind flank of nude mice. METHODS: When the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jang, B. S., Lee, S. -M., Kim, H. S., Shin, I. S., Razjouyan, F., Wang, S., Yao, Z., Pastan, I., Dreher, M. R., Paik, C. H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3309070/
https://ncbi.nlm.nih.gov/pubmed/22172384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2011.10.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados